Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Earlier from Noxopharm
- Reinstatement to Quotation
- Noxopharm Successfully Raises $1.5 Million via Placement
- Voluntary Suspension
- Trading Halt
- Novel oligonucleotides data presented at Options Conference
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm